Hologic, Inc. (BMV:HOLX)

Market Cap	287.80B -11.2%
Revenue (ttm)	73.91B +2.2%
Net Income	9.74B -26.9%
EPS	43.04 -23.8%
Shares Out	n/a
PE Ratio	29.55
Forward PE	16.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14
Average Volume	13
Open	1,260.00
Previous Close	1,263.00
Day's Range	1,260.00 - 1,260.00
52-Week Range	1,260.00 - 1,263.00
Beta	n/a
RSI	n/a
Earnings Date	Jan 29, 2026

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 1985
• Employees: 7,070
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: HOLX

Financial Performance

In fiscal year 2025, Hologic's revenue was $4.10 billion, an increase of 1.74% compared to the previous year's $4.03 billion. Earnings were $565.70 million, a decrease of -28.35%.

Financial numbers in USD